A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
Trial Parameters
Brief Summary
The purpose of the study is to evaluate the safety of SPH9788 tablets in healthy subjects.
Eligibility Criteria
Inclusion Criteria: 1. Healthy male and female subjects aged from 18 to 45 years; 2. Subject has a Body Mass Index (BMI) between 18.5 and 28.0 kg/m2 at screening and the weight of male subjects is not less than 50 kg, and the weight of female subjects is not less than 45 kg;; 3. Subjects who voluntarily participate and sign informed consent form; 4. Subjects who can communicate well with investigator and comply with the lifestyle restrictions specified in the protocol, and cooperate to complete the trial procedure; 5. Subjects willing to use reliable contraceptive methods throughout the trial and for 6 months after trial completion. Exclusion Criteria: 1. Medical history (current or past) that in the investigator's judgment may interfere with trial participation; 2. Surgical/medical conditions that may significantly affect drug pharmacokinetics (absorption, distribution, metabolism, excretion) or pose safety risks; 3. Occurrence of protocol-defined exclusionary events within 3 months p